Device type · LSW
Anti-Dna Antibody, Antigen And Control
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
LSW
Immunology
Device class
Class II
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Anti-Dna Antibody, Antigen And Control
- Product code
- LSW
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5100
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for LSW
Latest FDA decisions
Aesku.Diagnostics GmbH & Co. KG
K172348 · Decided Feb 16, 2018 · 197 days after receipt
Device type: Anti-Dna Antibody, Antigen And Control (LSW) · Laboratory Medicine & Pathology
K152013 · Decided Apr 11, 2016 · 265 days after receipt
Device type: Anti-Dna Antibody, Antigen And Control (LSW) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1107-2021 · Started Dec 14, 2020 · Posted by FDA Feb 11, 2021
Reason given: Decreased values for EliA ANA Positive Control when using the EliA dsDNA Well lot BFA37/0142 may potentially cause false positive results (increase in patient test results).
Cause as FDA categorized it: Under Investigation by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.